Pathogenesis of IgA nephropathy

Nephrology

Volumn 3, Issue 1, 1997, Pages 3-12

  Van Es, L A ^a   De Fijter, J W ^a   Daha, M R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cytokines; IgA responses; inflammation; proliferative responses

Indexed keywords

AUTOANTIGEN; BACTERIAL ANTIGEN; CYTOKINE; FOOD ANTIGEN; IMMUNOGLOBULIN A; VIRUS ANTIGEN;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; GENETIC PREDISPOSITION; GLOMERULITIS; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; KIDNEY FAILURE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL;

EID: 0030974534     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00180.x     Document Type: Conference Paper

References (89)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 1987; 245: 709-27.
2. Arima S, Nakayama M, Naito M, Sato T, Takahashi K. Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int. 1991; 39: 684-92.
3. Hai-Ling Li, Hancock WW, Dowling JP, Atkins RC. Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int. 1991; 39: 793-8.
4. Mackensen-Haen S, Eissele R, Bohle A. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis. Lab. Invest. 1988; 59: 239-44.
5. Gärtner HV, Hönlein F, Traub U, Bohle A. IgA nephropathy (IgA-IgG nephropathy/IgA nephritis) - a disease entity? Virchows Arch. Path. Anat. Histol. 1979; 385: 1-27.
6. Rodicio JL. Idiopathic IgA nephropathy. Kidney Int. 1984; 25: 717-29.
7. 1 in primary IgA nephropathy. Kidney Int. 1984; 26: 760-6.
8. Rauterberg EW, Lieberknecht HM, Wingen AM, Ritz E. Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int. 1987; 31: 820-9.
9. Dysart NK, Sisson S, Vernier RL. Immunoelectron microscopy of IgA nephropathy. Clin. Immunol. Immunopathol. 1983; 29: 254-70.
10. Thomas M, Ibels LS, Abbot N. IgA nephropathy associated with mastitis and haematuria. BMJ 1985; 291: 867-8.
11. Ibels LS, Györy AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79-102.
12. Yoshikawa N, Iijima K, Matsuyama S et al. Repeat renal biopsy in children with IgA nephropathy. Clin. Nephrol. 1990; 33: 160-7.
13. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q. J. Med. 1984; 210: 227-50.
14. Neelakantappa K, Gallo GR, Baldwin DS. Proteinuria in IgA nephropathy. Kidney Int. 1988; 33: 716-21.
15. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin. Nephrol. 1992; 37: 235-8.
16. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am. J. Kidney Dis. 1991; 18: 12-19.
17. Hoy WE, Hughson MD, Smith SM, Megill DM. Mesangial proliferative glomerulonephritis in Southwestern American Indians. Am. J. Kidney Dis. 1993; 21: 486-96.
18. Julian BA, Quiggins PA, Thompson JS et al. Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N. Engl. J. Med. 1985; 312: 202-8.
19. Schena FP, Scivittaro V, Ranieri E et al. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. Clin. Exp. Immunol. 1993; 92: 139-44.
20. Egido J, Julian BA, Wyatt RJ. Genetic factors in primary IgA nephropathy. Nephrol. Dial. Transplant. 1987; 2: 134-42.
21. Medcraft J, Hitman GA, Sachs JA et al. Autoimmune renal disease and tumour necrosis factor β gene polymorphism. Clin. Nephrol. 1993; 40: 63-8.
22. Lévy M, Lesavre P. Genetic factors in IgA nephropathy (Berger's disease). Adv. Nephrol. 1992; 21: 23-49.
23. Rambausek MH, Waldherr R, Ritz E. Immunogenetic findings in glomerulonephritis. Kidney Int. 1993; 43: S3-8.
24. Demaine AG, Rambausek M, Knight JF et al. Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J. Clin. Invest. 1988; 81: 611-14.
25. Hunley TE, Julian BA, Phillips III JA et al. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 1996; 49: 571-7.
26. Carter JE, Cimolai N. IgA nephropathy associated with campylobacter jejuni enteritis. Nephron 1991; 58: 101-2.
27. Friedberg M, Denneberg T, Brun C, Hannover Larsen J, Larsen S. Glomerulonephritis in infections with Yersinia enterocolitica O-serotype 3. Acta Med. Scand. 1981; 209: 103-10.
28. Kanayama Y, Shiota K, Kotumi K et al. Mycoplasma pneumoniae pneumonia associated with IgA nephropathy. Scan. J. Infect. Dis. 1982; 14: 231-3.
29. Kunimoto M, Hayashi Y, Kuki K et al. Analysis of viral infection in patients with IgA nephropathy. Acta Otolaryngol. 1993; 508: 11-18.
30. Ström EH, Dürmüller U, Gudat F, Mihatsch MJ. Hepatitis C virus plays no role in the pathogenesis of immunoglobulin A nephropathy in liver cirrhosis. Nephron 1994; 67: 370.
31. Coppo R, Roccatello D, Amore A et al. Effects of a gluten-free diet in primary IgA nephropathy. Clin. Nephrol. 1990; 33: 72-86.
32. Fornasieri A, Sinico RA, Maldifassi P et al. IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). BMJ 1987; 295: 78-80.
33. Rostoker G, Petit-Phar M, Delprato S et al. Mucosal immunity in primary glomerulonephritis: II. Study of the serum IgA subclass repertoire to food and airborne antigens. Nephron 1991; 59: 561-6.
34. Russell MW, Mestecky J, Julian BA, Galla JH. IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J. Clin. Immunol. 1986; 6: 74-86.
35. Murakami T, Kawakami H. Questionable role of soy protein in childhood IgA nephropathy. Nephron 1993; 64: 395-8.
36. Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol. Dial. Transplant. 1994; 9: 309-12.
37. Sanfilippo F, Croker BP, Bollinger RR. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 1982; 33: 370-6.
38. Baart de la Faille-Kuyper EH, Kater L, Kuijten RH et al. Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease. Kidney Int. 1976; 9: 424-9.
39. Lopez Trascasa M, Egido J, Sancho J, Hernando L. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin. Exp. Immunol. 1980; 42: 247-54.
40. Jones CL, Powell HR, Kincaid-Smith P, Roberton DM. Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int. 1990; 38: 323-31.
41. Feehally J, Beattie TJ, Brenchley PEC et al. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int. 1986; 30: 924-31.
42. Davin JC, Foidart JB, Mahieu PR. Relation between biological IgA abnormalities and mesangial IgA deposits in isolated hematuria in childhood. Clin. Nephrol. 1987; 28: 73-80.
43. Feehally J. Immune mechanisms in glomerular IgA deposition. Nephrol. Dial. Transplant. 1988; 3: 361-78.
44. Van Es LA. Pathogenesis of IgA nephropathy. Kidney Int. 1992; 41: 1720-9.
45. Van den Wall Bake AWL, Daha MR, Vam der Ark A et al. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin. Exp. Immunol. 1988; 74: 115-20.
46. Schwartz AL, Rup D. Biosynthesis of the human Asialoglycoprotein receptor. J. Biol. Chem. 1983; 258: 11249-55.
47. Bogers WMJM, Stad RK, Janssen DJ et al. Kuffper cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat endothelial cells. Clin. Exp. Immunol. 1991; 85: 128-36.
48. Roccatello D, Picciotto G, Ropolo R et al. Kinetics and fare of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy. Lab. Invest. 1992; 66: 86-95.
49. Fortune F, Courteau M, Williams DG, Lehner T. T and B cell responses following subcutaneous immunization with tetanus toxoid in IgA nephropathy. Clin. Exp. Immunol. 1992; 88: 62-7.
50. Layward L, Allen AC, Harper SJ, Hattersley JM, Feehally J. Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin. Exp. Immunol. 1992; 88: 394-8.
51. Van den Wall Bake AWL, Beyer WEP, Evers-Schouten JH et al. Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. J. Clin. Invest. 1989; 84: 1070-5.
52. Leinikki PO, Mustonen J, Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin. Exp. Immunol. 1987; 68: 33-8.
53. Waldo FB, Cochran AM. Systemic immune response to oral polio immunization in patients with IgA nephropathy. J. Clin. Lab. Immunol. 1989; 28: 109-14.
54. 1 by the bone marrow in IgA nephropathy. Kidney Int. 1989; 35: 1400-4.
55. De Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int. 1996 (in press).
56. Van den Wall Bake AWL, Kirk KA, Gay RE et al. Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection. Kidney Int. 1992; 42: 374-82.
57. O'Donoghue DJ, Darvill A, Ballardie FW. Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura. J. Clin. Invest. 1991; 88: 1522-30.
58. Wang MX, Walker RG, Kincaid-Smith P. Clinicopathologic associations of anti-endothelial cell antibodies in immunoglobulin A nephropathy and lupus nephritis. Am. J. Kidney Dis. 1993; 22: 378-86.
59. Sinico RA, Tadros M, Radice A et al. Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. Clin. Immunol. Immunopathol. 1994; 73: 19-26.
60. Cederholm B, Wieslander J, Bygren P, Heinegard D. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc. Natl Acad. Sci. USA 1988; 85: 4865-8.
61. Gomez-Querrero C, Gonzalez E, Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J. Immunol. 1993; 151: 7172-81.
62. Hai-Ling LI, Hancock WW, Hook DH, Dowling JP, Atkins RC. Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents. Kidney Int. 1990; 37: 1552-6.
63. Wyatt RJ. The complement system in IgA nephropathy and Henoch-Schönlein purpura: functional and genetic aspects. Contrib. Nephrol. 1993; 104: 82-91.
64. Yoshioka K, Takemura T, Akano N et al. IgA nephropathy in patients with congenital C9 deficiency. Kidney Int. 1992; 42: 1253-8.
65. Rits M, Hiemstra PS, Bazin H et al. Activation of rat complement by soluble and insoluble rat IgA immune complexes. Eur. J. Immunol. 1988; 18: 1873-80.
66. Van den Dobbelsteen MEA, Van der Woude FJ, Schroeijers WEM et al. Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int. 1994; 46: 512-19.
67. Rovin RH, Yoshimura T, Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells J. Immunol. 1992; 148: 2148-53.
68. Tomino Y, Ohmuro H, Kuramoto T et al. Expression of intercellular adhesion molecule-1 and infiltration of lymphocytes in glomeruli of patients with IgA nephropathy. Nephron 1994; 67: 302-7.
69. Floege J, Eng E, Young BA, Johnson RJ. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int. 1993; 43: S47-54.
70. Wolf G, Zahner R, Schroeder R, Stahl AK. Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol. Dial. Transplant. 1996; 11: 263-9.
71. Kohno M, Horio T, Ikeda M et al. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 1992; 42: 860-6.
72. Yoshioka K, Takemura T, Murakami K et al. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 1993; 68: 154-63.
73. Gesualdo L, Pinzani M, Floriano JJ et al. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab. Invest. 1991; 65: 160-7.
74. Yoshioka K, Takemura T, Murakami K et al. In situ expression of cytokines in IgA nephritis. Kidney Int. 1993; 44: 825-33.
75. Ruef C, Budde K, Lacy J et al. Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int. 1990; 38: 249-57.
76. Dohi K, Iwano M, Muraguchi A et al. The prognostic significance of urinary interleukin-6 in IgA nephropathy. Clin. Nephrol. 1991; 35: 1-5.
77. Yokoyama K, Takaeda M, Wada W. Intraglomerular expression of MHC Class II and Ki-67 antigens and serum γ-interferon levels in IgA nephropathy. Nephron 1992; 62: 169-75.
78. Prodjosudjadi W, Gerritsma JSJ, Klar-Mohamad N et al. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 1995; 48: 1477-86.
79. Boswell RN, Yard RA, Schrama E et al. Interleukin 6 production by proximal tubular epithelial cells in vitro: analysis of the effects of interleukin 1α (IL-1α) and other cytokines. Nephrol Dial. Transplant. 1994; 9: 599-606.
80. Gerritsma JSJ, Hiemstra PS, Gerritsen AF et al. Regulation and production of IL-8 human proximal tubular epithelial cells in vitro. Clin. Exp. Immunol. 1996; 103: 289-94.
81. Yard BA, Daha MR, Kooymans-Couthino M et al. IL-1α stimulated TNFα production by cultured human proximal tubular epithelial cells. Kidney Int. 1992; 42: 383-9.
82. Tikkanen I, Uhlenius N, Tikkanen T et al. Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis. Nephrol. Dial. Transplant. 1995; 10: 2192-8.
83. Prodjosudjadi W, Gerritsma JSJ, Van Es LA, Daha MR, Bruijn JA. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin. Nephrol. 1995; 44: 148-55.
84. Mariyama T, Fujiwara Y, Kaneko T et al. Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells. J. Am. Soc. Nephrol. 1995; 6: 95-101.
85. Wolf G, Neilson EG. Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int. 1993; 43: 100-7.
86. Paul M, Wagner J, Dzau VJ. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J. Clin. Invest. 1993; 91: 2058-64.
87. Pimentel JL, Sundell CL, Wang S et al. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int. 1995; 48: 1233-46.
88. Goumenos DA, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol. Dial. Transplant. 1994; 9: 1418-25.
89. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointestitial fibrosis. Kidney Int. 1991; 39: 550-6.